Vaccine hesitancy highest among Black and Hispanic or Latino health care workers; concerns include side effects, newness of vaccine
MONDAY, Aug. 30, 2021 (HealthDay News) — Before authorization of the COVID-19 vaccine, vaccine hesitancy was increased among Black, Hispanic or Latino, and Asian health care workers (HCWs) compared with White HCWs, according to a study published online Aug. 30 in JAMA Network Open.
Florence M. Momplaisir, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues examined hesitancy to COVID-19 vaccination among HCWs across different racial/ethnic groups in a survey study conducted over a three-week period in November and December 2020. A total of 12,034 individuals (34.5 percent of those who were eligible) completed the survey, and 10,871 (32.2 percent) completed the survey and also reported their race/ethnicity.
The researchers found that vaccine hesitancy was highest among Black HCWs and Hispanic or Latino HCWs (83.0 and 63.5 percent, respectively). Of the 5,440 HCWs with vaccine hesitancy, concerns about side effects, newness of the vaccine, and lack of vaccine knowledge were included as reasons (87.1, 79.2, and 75.2 percent, respectively). Compared with White HCWs, the adjusted odds ratios for vaccine hesitancy were 4.98, 2.10, 1.48, and 1.47 for Black HCWs, Hispanic and Latino HCWs, HCWs with other or mixed race/ethnicity, and Asian HCWs, respectively.
“These results suggest that more work is needed to ensure confidence in COVID-19 vaccination, particularly among Black and Hispanic or Latino individuals, who are disproportionately impacted by the pandemic,” the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
Trends Reported in Vaccination Coverage for Adolescents for 2025